Investing News Long-Term Statistics on Lynparza by AstraZeneca/Merck Demonstrate a Benefit for Survival in Ovarian Cancer Patients September 9, 2022
Investing News Roche will pay $250 million upfront to purchase Good Therapeutics in order to expand its immuno-oncology offering September 7, 2022